Skip to content
NeuroTechGuide

INBRAIN completes the first-in-human study of a graphene brain interface

In a University of Manchester study during brain tumor surgery, the graphene array recorded high-resolution signals with no device-related adverse events.

In briefClinical trialsImplants

INBRAIN Neuroelectronics has completed enrollment in the first human study of graphene neural interfaces, sponsored by the University of Manchester with the Northern Care Alliance NHS Foundation Trust. Of 10 patients recruited, eight were treated during brain tumor surgery. The company reports no device-related adverse events or device failures, and during awake surgery the thin graphene array captured high-resolution signals while patients named objects. Full results are expected after a 90-day follow-up.

Graphene is thinner and potentially more sensitive than metal electrodes, and these are the first human data for it.

Learn more: ECoG · INBRAIN Neuroelectronics

Share:XLinkedInBlueskyEmail

More news